Homira Osman

Dr. Homira Osman is the vice-president of research, public policy, and programs at Muscular Dystrophy Canada. She has conducted extensive research on the high usage rates of immunoglobulin in Canada, identifying systemic factors that contribute to its overprescription. Her work aims to improve the understanding and regulation of immunoglobulin use, ensuring that patients receive appropriate treatment while managing the finite resources derived from human plasma.